by Gemma Escarré,
Bio€quity Europe, the longest investor event for the European biotechnology sector, will take place in Barcelona for the first time on 20th and 21st May 2019. The conference will be held in Barcelona at the initiative of the Host Regional Committee, which brings together Biocat, Ysios Capital, ACCIÓ and CataloniaBio & HealthTech.
Bio€quity Europe —organised by BioCentury and EBD Group— has showcased more than 800 leading European companies and thousands of investment and pharma business development professionals. More than 550 delegates from 26 nations attended latest edition in Ghent.
"Barcelona has all of the key ingredients for a vibrant life sciences ecosystem: a solid academic science, a risk-taking, entrepreneurial culture and a growing pool of venture capital" says Eric Pierce, Publisher at BioCentury.
Jordi Naval, Strategy Director of Biocat, emphasizes the significance of this investors’ conference in Barcelona: "Bio€quity will allow us showcase how Barcelona and the BioRegion of Catalonia have become a destination of choice for biotech investment in Europe. In the last years our biotech companies have attracted an average of €135 million/year in investment. There are over 40 international investors participating in life sciences companies already —most of them from US— and the figure has almost doubled in just two years".
Joan Romero, CEO of Catalonia Trade & Investment, stresses that “connections with international investors are key to the growth and development of the hub of 1,250 Catalan start-ups".
On the other hand, Joël Jean-Mairet, Managing Partner at Ysios Capital, comments “Barcelona is becoming a hot biotech hub in Europe, and hosting Bio€quity will allow international investors to interact with local biotech companies and to see first-hand the evolution of the rising Catalan biotechnology ecosystem.”
Jaume Amat, president of the association of companies CataloniaBio & HealthTech and CEO of Specipig, says, “we have a growing, maturing ecosystem, as can be seen in the data from the latest Study on investment in the Biomedical industry in Catalonia we published with EY, and this fair can be a good catalyst to attract more investment that will speed up the transfer of innovative medicines and medical technology to market.”